[1] Airola MV, Hannun YA.Sphingolipid metabolism and neutral sphingomyelinases[J]. Handb Exp Pharmacol, 2013,(215):57-76. [2] Lv Y, Zhang CD, Wang YL, et al.Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains[J]. Gastric Cancer, 2021, 24(6):1293-1306. [3] Chen Y, Ma Z, Min L, et al.Biomarker identification and pathway analysis by serum metabolomics of lung cancer[J]. Biomed Res Int, 2015, 2015:183624. [4] Hertervig E, Nilsson A, Nyberg L, Duan RD.Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma[J]. Cancer, 1997, 79(3):448-453. [5] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [6] Magini P, Smits DJ, Vandervore L, et al.Loss of SMPD4 Causes a Developmental Disorder Characterized by Microcephaly and Congenital Arthrogryposis[J]. Am J Hum Genet, 2019, 105(4):689-705. [7] Barnholz Y, Roitman A, Gatt S.Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain[J]. J Biol Chem, 1966, 241(16):3731-3737. [8] Ferranti CS, Cheng J, Thompson C, et al.Fusion of lysosomes to plasma membrane initiates radiation-induced apoptosis[J]. J Cell Biol, 2020, 219(4): e201903176. [9] Peña LA, Fuks Z, Kolesnick RN.Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency[J]. Cancer Res, 2000, 60(2):321-327. [10] Paris F, Fuks Z, Kang A, et al.Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice[J]. Science, 2001, 293(5528):293-297. [11] El Kaffas A, Al-Mahrouki A, Hashim A, et al.Role of Acid Sphingomyelinase and Ceramide in Mechano-Acoustic Enhancement of Tumor Radiation Responses[J]. J Natl Cancer Inst,2018,110(9):1009-1018. [12] Rana S, Espinosa-Diez C, Ruhl R, et al.Differential regulation of microRNA-15a by radiation affects angiogenesis and tumor growth via modulation of acid sphingomyelinase[J]. Sci Rep, 2020, 10(1):5581. [13] Zhang CD, Wang YL, Zhou DM, et al.A recombinant Chinese measles virus vaccine strain rMV-Hu191 inhibits human colorectal cancer growth through inducing autophagy and apoptosis regulating by PI3K/AKT pathway[J]. Transl Oncol, 2021,14(7):101091. [14] Chakraborty P, Vaena SG, Thyagarajan K, et al. Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity [J]. Cell Rep, 2019, 28(7):1879-1893.e7. [15] Montfort A, Bertrand F, Rochotte J, et al.Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy[J]. Cancer Immunol Res, 2021, 9(5):568-582. [16] 简心韵,邓子新,孙宇辉.氨基糖苷抗生素庆大霉素:基础研究的新进展及应用研究的新潜力[J].生物工程学报,2015,31(6):829-844. [17] Albi E, Cataldi S, Ceccarini MR, et al.Gentamicin Targets Acid Sphingomyelinase in Cancer: The Case of the Human Gastric Cancer NCI-N87 Cells[J]. Int J Mol Sci, 2019, 20(18):4375. [18] Park MA, Zhang G, Martin AP, et al.Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation[J]. Cancer Biol Ther, 2008, 7(10):1648-1662. [19] Savić R, He X, Fiel I, et al.Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer[J]. PLoS One, 2013, 8(5): e65620. [20] Osawa Y, Suetsugu A, Matsushima-Nishiwaki R, et al.Liver acid sphingomyelinase inhibits growth of metastatic colon cancer[J]. J Clin Invest, 2013,123(2):834-843. [21] Ordoñez R, Fernández A, Prieto-Domínguez N, et al.Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells[J]. J Pineal Res, 2015, 59(2):178-189. [22] Fucho R, Martínez L, Baulies A, et al.ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis[J]. J Hepatol, 2014, 61(5):1126-1134. [23] Antoon JW, White MD, Burow ME, et al.Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance[J]. Oncol Rep, 2012, 27(6):1779-1786. [24] Jung JH, Taniguchi K, Lee HM, et al.Comparative lipidomics of 5-Fluorouracil-sensitive and -resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1)[J]. Sci Rep, 2020, 10(1):6124. [25] Zhang L, Dai J, Zeng Z, et al.Nitric oxide induces HepG2 cell death via extracellular signal-regulated protein kinase activation by regulating acid sphingomyelinase[J]. Mol Biol Rep, 2020, 47(10):8353-8359. [26] Clarke CJ, Wu BX, Hannun YA.The neutral sphingomyelinase family: identifying biochemical connections[J]. Adv Enzyme Regul, 2011, 51(1):51-58. [27] Momchilova A, Nikolaev G, Pankov S, et al.Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells[J]. Int J Mol Sci, 2022, 23(22): 13916. [28] Tomiuk S, Zumbansen M, Stoffel W.Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase[J]. J Biol Chem, 2000, 275(8):5710-5717. [29] Lin M, Liao W, Dong M, et al.Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide[J]. FEBS J, 2018, 285(20):3835-3848. [30] Zhong L, Kong JN, Dinkins MB, et al.Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice[J]. J Lipid Res, 2018, 59(5):795-804. [31] Revill K, Wang T, Lachenmayer A, et al. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma [J]. Gastroenterology, 2013, 145(6):1424-35. e1-25. [32] Nemoto S, Nakamura M, Osawa Y, et al.Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation[J]. J Biol Chem, 2009, 284(16):10422-10432. [33] Liu X, Wu J, Zhang D, et al.Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis[J]. Front Genet, 2018, 9:265. [34] Shen Y, Takahashi M, Byun HM, et al.Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells[J]. Cancer Biol Ther, 2012, 13(7):542-552. [35] Datta A, Kim H, McGee L, et al. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer[J]. Sci Rep, 2018, 8(1): 8161. [36] Richards KE, Zeleniak AE, Fishel ML, et al.Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells[J]. Oncogene, 2017, 36(13): 1770-1778. [37] Moloudizargari M, Hekmatirad S, Gharaghani S, et al.Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy[J]. J Cancer Res Clin Oncol, 2023. [38] Wang L, Chen X, Meng F, et al.α2,6-Sialylation promotes hepatocellular carcinoma cells migration and invasion via enhancement of nSmase2-mediated exosomal miRNA sorting[J]. J Physiol Biochem, 2023, 79(1): 19-34. [39] Wu BX, Clarke CJ, Hannun YA.Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses[J]. Neuromolecular Med, 2010, 12(4): 320-330. [40] Atilla-Gokcumen GE, Muro E, Relat-Goberna J, et al.Dividing cells regulate their lipid composition and localization[J]. Cell, 2014, 156(3): 428-439. [41] Hu B, Yang XB, Sang XT.Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma[J]. Cancer Med, 2020, 9(20): 7646-7662. [42] Wu BX, Rajagopalan V, Roddy PL, et al.Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5[J]. J Biol Chem, 2010, 285(23): 17993-18002. [43] Nilsson A.The presence of sphingomyelin-and-ceramide-cleaving enzymes in the small intestinal tract[J]. Biochim Biophys Acta, 1969, 176(2): 339-347. [44] Duan RD, Bergman T, Xu N, et al.Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family[J]. J Biol Chem, 2003, 278(40): 38528-38536. [45] Wu J, Cheng Y, Palmberg C, et al.Cloning of alkaline sphingomyelinase from rat intestinal mucosa and adjusting of the hypothetical protein XP_221184 in GenBank[J]. Biochim Biophys Acta, 2005, 1687(1-3): 94-102. [46] Duan RD, Nilsson A.Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development[J]. Prog Lipid Res, 2009, 48(1): 62-72. [47] Chen Y, Zhang P, Xu SC, et al.Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice[J]. Mol Cancer Ther, 2015, 14(1): 259-267. [48] 张萍, 袁丽杰, 赵蕾, 等. 鞘磷脂水解产物对结肠癌细胞中碱性鞘磷脂酶的影响[J]. 癌变.畸变.突变, 2009,21(6): 418-421. [49] Cheng Y, Wu J, Hertervig E, et al.Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis[J]. Br J Cancer, 2007, 97(10): 1441-1448. [50] Duan RD, Hindorf U, Cheng Y, et al.Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography[J]. BMC Gastroenterol, 2014, 14: 138. |